StonvexLoading…
StonvexStonvexStonvexCore line items from SBGI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.17B | $3.55B | $3.13B | $3.93B |
Operating Income | $173.00M | $551.00M | $-331.00M | $3.98B |
Net Income | $-112.00M | $310.00M | $-291.00M | $2.65B |
EPS (Diluted) | $-1.61 | $4.69 | $-4.46 | $37.54 |
Total Assets | $5.95B | $5.88B | $6.08B | $6.70B |
Total Liabilities | $5.58B | $5.37B | $5.86B | $5.83B |
Cash & Equivalents | $866.00M | $697.00M | $662.00M | $884.00M |
Free Cash Flow OCF − CapEx | $115.00M | $14.00M | $143.00M | $694.00M |
Shares Outstanding | 69.12M | 66.10M | 65.13M | 70.66M |